D.E. Shaw & Co’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,584
| Closed | -$23.2K | – | 4682 |
|
|
2024
Q3 | $23.2K | Sell |
25,584
-120,607
| -82% | -$112K | ﹤0.01% | 4334 |
|
|
2024
Q2 | $146K | Sell |
146,191
-40,436
| -22% | -$44.7K | ﹤0.01% | 4127 |
|
|
2024
Q1 | $276K | Buy |
+186,627
| New | +$212K | ﹤0.01% | 3771 |
|
|
2023
Q4 | – | Sell |
-51,220
| Closed | -$60.4K | – | 4493 |
|
|
2023
Q3 | $60.4K | Sell |
51,220
-71,461
| -58% | -$97.2K | ﹤0.01% | 3903 |
|
|
2023
Q2 | $173K | Buy |
+122,681
| New | +$170K | ﹤0.01% | 3767 |
|
|
2022
Q3 | – | Sell |
-10,886
| Closed | -$17K | – | 5382 |
|
|
2022
Q2 | $17K | Sell |
10,886
-44,585
| -80% | -$58.8K | ﹤0.01% | 5047 |
|
|
2022
Q1 | $85K | Sell |
55,471
-199,346
| -78% | -$309K | ﹤0.01% | 5032 |
|
|
2021
Q4 | $624K | Buy |
254,817
+67,331
| +36% | +$158K | ﹤0.01% | 4274 |
|
|
2021
Q3 | $472K | Buy |
187,486
+162,267
| +643% | +$416K | ﹤0.01% | 4119 |
|
|
2021
Q2 | $72K | Buy |
+25,219
| New | +$65.3K | ﹤0.01% | 4596 |
|
|
2019
Q4 | – | Sell |
-10,354
| Closed | -$10K | – | 4100 |
|
|
2019
Q3 | $10K | Buy |
+10,354
| New | +$10.7K | ﹤0.01% | 3765 |
|
|
2018
Q2 | – | Sell |
-15,386
| Closed | -$36K | – | 3816 |
|
|
2018
Q1 | $36K | Sell |
15,386
-114,543
| -88% | -$269K | ﹤0.01% | 3435 |
|
|
2017
Q4 | $244K | Sell |
129,929
-427
| -0.3% | -$932 | ﹤0.01% | 3341 |
|
|
2017
Q3 | $324K | Buy |
130,356
+47,513
| +57% | +$118K | ﹤0.01% | 3111 |
|
|
2017
Q2 | $228K | Sell |
82,843
-54,643
| -40% | -$153K | ﹤0.01% | 3146 |
|
|
2017
Q1 | $415K | Buy |
137,486
+10,301
| +8% | +$29.3K | ﹤0.01% | 2822 |
|
|
2016
Q4 | $402K | Buy |
127,185
+33,790
| +36% | +$104K | ﹤0.01% | 2976 |
|
|
2016
Q3 | $319K | Buy |
93,395
+74,404
| +392% | +$206K | ﹤0.01% | 3021 |
|
|
2016
Q2 | $43K | Sell |
18,991
-42,394
| -69% | -$104K | ﹤0.01% | 3292 |
|
|
2016
Q1 | $154K | Buy |
61,385
+9,444
| +18% | +$21.1K | ﹤0.01% | 3233 |
|
|
2015
Q4 | $172K | Buy |
51,941
+23,710
| +84% | +$70.9K | ﹤0.01% | 3596 |
|
|
2015
Q3 | $68K | Sell |
28,231
-20,033
| -42% | -$51.9K | ﹤0.01% | 3643 |
|
|
2015
Q2 | $141K | Buy |
48,264
+1,528
| +3% | +$5.92K | ﹤0.01% | 3623 |
|
|
2015
Q1 | $187K | Buy |
46,736
+7,219
| +18% | +$25K | ﹤0.01% | 3459 |
|
|
2014
Q4 | $119K | Buy |
39,517
+3,064
| +8% | +$8.29K | ﹤0.01% | 3884 |
|
|
2014
Q3 | $92K | Sell |
36,453
-26,050
| -42% | -$62.7K | ﹤0.01% | 3993 |
|
|
2014
Q2 | $154K | Buy |
62,503
+1,379
| +2% | +$3.11K | ﹤0.01% | 4037 |
|
|
2014
Q1 | $162K | Sell |
61,124
-35,384
| -37% | -$104K | ﹤0.01% | 4124 |
|
|
2013
Q4 | $280K | Buy |
+96,508
| New | +$292K | ﹤0.01% | 4093 |
|
Other funds holding LCTX
BC
PA
DC
RA
DCM